Egyptian International Pharmaceutical Industries Company (CASE: PHAR)
Health Care · Pharmaceuticals · EG
EGP131.50
-8.04% today · +144.2% 1Y
Egyptian International Pharmaceutical Industries Company (CASE: PHAR) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $436.17M.
Over the last twelve months the share price has gained 144.2%, trading between 53.10 and 178.99.
Tweenvest scores Egyptian International Pharmaceutical Industries Company across four factors: quality 55/100, value 36/100, growth 49/100, dividend 54/100. Its strongest factor is quality.
PHAR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $436.17M
- Revenue (TTM)
- $201.18M
- P/E
- 17.19
- EPS
- 7.65
- Dividend yield
- 1.14%
- Beta (5Y)
- 0.53
- 52-week high
- EGP178.99
- 52-week low
- EGP53.10
- Avg volume (3M)
- —
- Shares outstanding
- 168.76M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.